Dr. Scott Hemby is the chair of basic pharmaceutical sciences in the Fred Wilson School of Pharmacy. Hemby led and published a new study about kratom, a plant that the scientific community and general public have debated regarding its potential to treat pain without being addictive. Hemby led a group of researchers from HPU, the University of Florida and the University of South Carolina to test whether two of the main constituents of the plant, mitragynine and 7-hydroxymitragynine, are addictive or may reduce opiate intake. Their findings were published in Addiction Biology, a peer-reviewed medical journal. Hemby has published more than 55 peer-reviewed scientific articles and 10 book chapters and served on more than 45 grant review committees for NIH and private foundations.
Expertise: Kratom, pharmaceutical sciences